Merge Healthcare revises backlog totals after internal investigation

Merge Healthcare (MRGE) says it "recently learned through an internal review that a former sales employee in its eClinical business had falsified the existence or amount of certain customer contracts."

No restatement of previously reported financial statements is necessary.

MRGE is reducing non-GAAP subscription backlog totals for the Merge DNA unit.

Here are the revised figures (in thousands): June 30, 2012, $21,936; September 30, 2012, $29,004; December 31, 2012, $29,108; March 31, 2013, $32,270; June 30, 2013, $37,432; September 30, 2013, $41,219.

Ultimately, the employee falsified $5.8M worth of contracts in 2012 and $9.4M last year. The (apparent) rationale: "The individual [likely] falsified these contracts in order to achieve sales quotas and receive additional commissions totaling approximately $250K." (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs